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Abstract: 
Objective: Maximal cardiopulmonary exercise testing (CPET) is the “gold 
standard” method of determining VO2peak. When CPET is unavailable, VO2peak 
may be estimated from treadmill or cycle ergometer workloads and expressed 
as estimated metabolic equivalents (METs). Cardiac rehabilitation (CR) 
programmes use estimated VO2peak (METs) to report changes in 
cardiorespiratory fitness (CRF). However, the accuracy of determining changes 
in VO2peak based on estimated functional capacity is not known. 
 
Methods: 27 patients with coronary heart disease (88.9% male; age 59.5 ± 
10.0 years, body mass index 29.6 ± 3.8 kg.m-2) performed maximal CPET 
before and after an exercise based CR intervention. VO2peak was directly 
determined using ventilatory gas exchange data and was also estimated using 
the American College of Sports Medicine (ACSM) leg cycling equation for 
METs. Agreement between changes in directly determined VO2peak and VO2peak 
estimated from METs was tested using Bland-Altman limits of agreement 
(LoA), and intraclass correlation coefficients.  
 
Results: Directly determined VO2peak did not increase significantly following CR 
(0.5 ml.kg-1.min-1 (2.7%); p=0.332). In contrast, estimated VO2peak increased 
significantly (0.4 METs; 1.4 ml.kg-1.min-1; 6.7%; p=0.006). The mean bias for 
estimated VO2peak versus directly-determined VO2peak was 0.7 ml
.kg-1.min-1 (LoA 
-4.7 to 5.9 ml.kg-1.min-1). Aerobic efficiency, (ΔVO2/ΔWR slope) was 
significantly associated with estimated VO2peak measurement error. 
 
4 
Conclusion: Changes in estimated VO2peak determined using the ACSM 
equation for leg cycling are not accurate surrogates for directly determined 
changes in VO2peak. Reporting mean CRF changes using estimated METs may 
over-estimate the efficacy of CR and lead to a different interpretation of study 
findings compared to directly determined VO2peak.  
 
Key Words: CHD, Coronary Heart Disease, Cardiac Rehab, Cardiovascular Rehab, 
Exercise Testing, Cardiopulmonary Exercise Testing, Metabolic Equivalents, METs   
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Introduction 
 
Structured exercise training is a core component of most cardiac rehabilitation (CR) 
programmes 1-4. The efficacy of exercise-based CR is predicated on appropriately 
personalised exercise training 5. Exercise prescriptions should be based on an 
individualised assessment that includes an initial exercise test. Maximal 
cardiopulmonary exercise testing (CPET) is the “gold standard” method for 
determining cardiorespiratory fitness [CRF] 6. Information obtained during CPET 
provides some of the most accurate data on which to base an exercise prescription 
and to determine changes in CRF following the completion of a CR programme.  
 
Where CPET is not available, workloads achieved during an incremental exercise test 
may be used to estimate VO2peak 
7 8. Estimates of VO2peak are often expressed as 
estimated metabolic equivalents (METs). Although recently challenged 8 equations for 
estimating VO2peak and METs are traditionally based on an assumed linear relationship 
between VO2 and work rate 
7. One MET (corresponding to resting metabolic rate) is 
assumed to equate to a VO2 of 3.5 ml
.kg-1.min-1 9. Increases in estimated functional 
capacity during an exercise test are commonly expressed in multiples of resting 
metabolic rate. Peak estimated METs achieved during maximal exercise testing are 
used to risk-stratify patients, prescribe individual exercise intensities for exercise 
training, and to determine changes in CRF following exercise interventions 10. 
However, estimates of functional capacity may not accurately quantify VO2peak, 
particularly during treadmill protocols 11-13. Whilst the limitations of estimating VO2peak 
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from a single exercise test are known, the accuracy of estimated changes in VO2peak 
following an exercise training intervention is unclear.  
 
Large discrepancies between estimated, and directly determined VO2peak have 
previously been reported 14 15. However, to our knowledge, the only relevant 
investigation in to the suitability of estimating VO2peak change from peak METs found 
no correlation (r=0.24; p=0.100) in 50 patients with coronary heart disease (CHD) 
undertaking maximal treadmill testing (Milani et al. 1995). Stuto, et al. (2013) also 
present data showing that the increase in directly determined VO2peak following CR 
(14.7%) was not accurately reflected by a much lower improvement in functional 
capacity (3.85%) following CR. Thus, in this elderly cohort of patients attending CR, 
change in estimated peak METs do not appear to reflect improvement in directly 
determined VO2peak. However this was not specifically addressed by Stuto, et al. 
16. We 
therefore aimed to investigate the accuracy of estimating changes in VO2peak using the 
American College of Sports Medicine 7 leg cycling equation in patients with CHD.  
 
 
Methods 
 
Study design  
Ethical approval was provided by the Yorkshire and the Humber NHS Research Ethics 
Committee (12/YH/0072). All patients provided written informed consent. All patients 
had agreed to participate in routine CR as delivered by their local National Health 
Service provider, and were a minimum of 28 days’ post cardiac event at the time of 
7 
baseline assessment (Visit 1). Patients were included if they had completed maximal 
CPET before (visit 1) and following the completion of their CR exercise programme 
(visit 2). Clinical information collected included cardiac diagnosis, past medical history, 
medications, smoking status, resting heart rate, blood pressure, waist circumference 
measurement, and body mass index (BMI). Ejection Fraction (EF) was determined 
from a resting echocardiogram. Patients with New York Heart Failure Classification 
(NYHA) IV, a left ventricular ejection fraction <30%, or a pacemaker/implantable 
cardioverter defibrillator, were excluded. 
 
Cardiac Rehabilitation Programme  
Patients were recruited from four different CR centres in Yorkshire and Northern 
Lincolnshire (UK) between January and March 2013. CR provision remains inequitable 
across the UK 17 18. The diversity of practice was reflected by the characteristics of the 
CR programmes included in this study. All CR programmes used interval circuit training 
with alternating cardiovascular and active recovery exercises. Exercise was prescribed 
at 40-70% of estimated heart rate reserve [HRR] using formulae recommended by the 
Association of Chartered Physiotherapist in Cardiac Rehabilitation 10. The programme 
length varied from 4-24 sessions conducted over a 4-12 week period. The median 
number of exercise sessions during follow up was 15 (range: 0 to 62). 
 
Cardiopulmonary Exercise Testing 
At baseline and after completion of training, patients undertook symptom-limited 
maximal CPET following a 25W, two-minute stage, incremental electronically-braked 
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cycle ergometer protocol (GE Healthcare e-Bike, Chalfont St Giles, United Kingdom). 
Patients started pedalling at 25W without a prior unloaded cycling phase. Breath-by-
breath metabolic gas measurements were collected via an Innocor (Innovision, 
Glamsbjerg, Denmark) metabolic cart.  Calibration was performed prior to each 
exercise test according to the manufacturer’s instructions. ECG and heart rate (HR) 
were continuously recorded using a GE Case System (GE Healthcare, Chalfont St Giles, 
United Kingdom) BP was monitored at two minute intervals using a Tango automated 
sphygmomanometer (SunTech Medical, Eynsham, United Kingdom). 
Exercise was terminated if a patient experienced chest pain or achieved any of the 
test termination criteria outlined by the American Thoracic Society (2003). Data were 
exported as breath-by-breath values and post-processed to generate 15 second 
averages using Microsoft Excel (Microsoft, Redmond WA, USE). VO
2peak and peak 
respiratory exchange ratio (RER) were both averaged over the final 30 seconds of 
CPET. VO2peak was standardised to body mass and reported as (ml
.kg-1.min-1). The 
ventilatory anaerobic threshold (VAT) was determined using the V-slope method 19 
and also reported standardised to body mass. The slope of VO2 as a function of work 
rate (ΔVO2/ΔWR slope), a measure of aerobic efficiency, was determined using linear 
regression from data obtained throughout the CPET. ΔVO2/ΔWR slope values <8.4 
mL/min-1/W were considered abnormal 9. Estimated peak METs were calculated using 
the ACSM 7 leg cycling equation:  
VO2 = (1.8 x kg
.m.min-1) / BM + (7.0) 
Where kg.m is Kilogram metres (and where 1W is equal to 6.12 kg.m.min-1) and BM is 
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patient body mass. The term ‘directly-determined’ VO2peak and ‘estimated VO2peak’ are 
used to distinguish between the two variables.  
Patients were asked to rate their perceived exertion (RPE) at the end of every two-
minute stage during and at peak exercise using the 6-20 Borg score (Borg, 1982). 
Instructions for the use of the Borg score were given to patients prior to CPET using a 
standardised list of terms.  
 
Statistical Analysis 
Statistical analysis was performed using SPSS version 22 (IBM, New York, USA). Data 
were visually assessed for normality and heteroscedasticity. Categorical data are 
reported as percentages. Continuous normally distributed variables are displayed as 
mean with 95% confidence intervals (95% CI) or standard deviation (±) where 
specified. Statistically significant differences (p < 0.05) were calculated using repeated 
measures analysis of variance (ANOVA) and repeated measures analysis of covariance 
(ANCOVA). Partial eta2
 
(ηp
2) effect sizes were also calculated with 0.01, 0.06 and 0.14 
representing small, medium, and large effect sizes respectively (Richardson, 2011). 
Pearson correlations were used to assess the strength of the relationship between 
variables. An r value of <0.25, 0.26 to 0.50, 0.51 to 0.75, and, >0.75 were considered 
weak, moderate, fair and strong associations, respectively 20. Intraclass correlation 
coefficients (ICC) and Bland-Altman analysis were used to assess agreement between 
measurement methods 21 22. The maximum acceptable difference between 
assessment methods was set at 3.5 ml.kg-1.min-1 (1 MET). A 1 MET increase in 
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functional capacity has been shown to carry significant survival benefits (12%) (Myers 
et at, 2002). A measurement error greater than 1 MET would not only suggest that 
estimates of VO2peak do not reliably interpret patient risk, but also that they are poor 
markers for monitoring CRF change.  A consensus on ICC strength has not been 
reached, but we defined moderate agreement as an ICC of 0.6–0.75, good agreement 
between 0.75 and 0.9 and excellent >0.9 22. 
 
 
Results 
 
Patient Characteristics  
 
Patient characteristics and medications at baseline are reported in Table 1. n=44 
patients conducted a baseline maximal CPET. n=17 were lost to follow-up. n=27 were 
included for analysis. (88.9% male; age 59.5 ± 10.0 years, body mass index [BMI] 29.6 
± 3.8 kg.m-2). The median number of exercise sessions conducted at follow up was 15 
(range: 0 to 62). Five patients failed to attend at least one exercise session. 
 
 
Cardiorespiratory Fitness Change 
 
Table 2 shows changes in key CPET variables. Despite a significant increase in exercise 
test duration and peak power output [watts], there was no significant change in 
directly-determined VO2peak (mean change: 2.7%; 0.5 ml
.kg-1.min-1; 95% CI: -0.6 to 1.8 
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ml.kg-1.min-1). There were no significant changes in peak HR or RPE (indicators of 
patient effort) between CPETs. Peak RER, however, was significantly higher at visit 2 
compared to visit 1. Change in directly determined VO2peak remained non-significant 
when RER change was considered as a covariate (mean change 0.6 ml.kg-1.min-1; 95% 
CI: -0.6 to 1.8 ml.kg-1.min-1 p=0.324).  
 
Consistent with the increased workload, there was a significant increase in estimated 
peak METs (mean change: 6.7%; 0.4 METs; 95% CI: 0.1 to 0.6 METs). This 
corresponded to an estimated VO2peak change of 1.4 ml
.kg-1.min-1. The VAT (mean 
change: 9.9%; 1.4 ml.kg-1.min-1; 95% CI: 0.5 to 2.3 ml.kg-1.min-1), and ventilatory 
efficiency slope (VE/VCO2 slope) also significantly improved following CR. The mean 
ΔVO2/ΔWR slope was within normal limits at both visits and did not change 
significantly between visits. However, 19% (n=10) of all exercise tests had a 
ΔVO2/ΔWR slope below the lower limit of normal (<8.4 mL/min/W).  
 
Agreement between Directly-Determined VO2peak and Estimated VO2peak  
 
Correlations and measures of agreement for CPET variables are presented in Table 3. 
There was a significant association between directly determined VO2peak and 
estimated VO2peak on both pre and post- cardiac rehabilitation visits Figure 1A and 1 
B). The mean bias and limits of agreement for estimated VO2peak on both tests are also 
presented in Table 3. The association between changes in directly-determined VO2peak 
and estimated VO2peak was substantially reduced (Figure 1C, r=0.527, p=0.05). 
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The ICC between the two measurements was not non-significant (ICC 0.358; 95% CI -
0.442 to 0.711; p=0.138). Bland-Altman Analysis (Figure 2) showed the mean bias for 
changes in VO2peak was less than the maximal acceptable difference (0.7 ml
.kg-1.min-1; 
95% CI -0.4 to 1.8 ml.kg-1.min-1; p=0.178; ηp
2= 0.069). However, the limits of agreement 
(LoA) were far wider (-4.7 to 5.9 ml.kg-1.min-1; lower LoA 95% CI: -5.1 to -4.3; upper 
LoA 95% CI: 5.5 to 6.3 ml.kg-1.min-1). VO2peak measurement error was greater than the 
maximal acceptable difference in 33%. There was a significant, moderate negative 
correlation between VO2peak measurement error (estimated VO2peak minus directly 
determined VO2peak) and ΔVO2/ΔWR slope (Figure 3, r=-0.496, p<0.001).  
 
Discussion 
 
We found that estimated METS derived from the ACSM leg cycling equation are 
significantly and consistently associated with directly-determined oxygen 
consumption in a representative cohort of patients attending CR. However, the LoA 
from our Bland-Altman analysis suggest that estimated functional capacity change 
does not accurately reflect directly determined VO2peak changes following a CR 
exercise training intervention. This is supported by our failure to find a significant ICC 
between the two measurements. 
 
Increasing VO2peak through structured exercise training improves survival 
23 in patients 
with CHD and, consequently, improving VO2peak remains a key objective for CR 
practitioners. Practitioners need to have confidence in the efficacy of the outcome 
measures they report. Given that CR programme outcome data are often expressed in 
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estimated METs, there is a requirement to examine the suitability of estimated 
functional capacity to accurately determine changes in VO2peak.  
 
Significant mean improvements in peak exercise time, power output and associated 
improvements in estimated METs following cardiac rehabilitation were not 
accompanied by improved mean peak oxygen consumption in the present study. 
These findings question the appropriateness of using estimated VO2peak (METs) as a 
surrogate indicator of improvements in VO2peak. Reporting estimated METs alone may 
lead to inaccurate interpretations of the efficacy of exercise interventions within 
rehabilitation settings. 
 
Estimating mean changes in VO2peak (through widely applied MET equations) over 
predicted actual VO2peak by more than two-fold in this patient group. These findings 
are consistent with previously published data 13 14 which indicate poor agreement 
between estimates of VO2peak change and directly determined VO2peak change. 
However, our findings contradict those of Stuto and colleagues (2013) who 
demonstrate a lower relative improvement in functional capacity (3.85%) compared 
to directly determined VO2peak (14.7%). The limited information provided within this 
study abstract limits comparison of study findings. However, these findings may have 
important implications when interpreting the CRF benefits of CR.  
  
Improvements in other aspects of cardiorespiratory fitness were observed following 
exercise training in this cohort. VAT significantly increased following exercise-based 
CR. Improvements in VAT are associated with increased endurance capacity, less 
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blood lactate accumulation and associated acid-base metabolic perturbations 24 25. 
Given VO2peak remained unchanged, changes in the VAT are likely to have contributed 
to improved exercise capacity and estimated MET changes. 
  
The failure of estimated MET change to accurately predict directly determined VO2peak 
change may in part, be attributed to test familiarisation and improved movement 
economy leading to a longer test duration 26 27. However, the use of a cycle ergometer 
as opposed to a treadmill may partially mitigate these factors. It is possible that the 
use of our step protocol (2 minute stages, 25W Increments) may have led to a weaker 
association between VO2 and work rate. Two minutes may have been inadequate time 
to attain VO2 steady-state. Less predictable VO2/work rate relationships have been 
observed in patients with cardiovascular disease. Poor oxygen uptake kinetics 
resulting from poor muscle oxygen extraction, myocardial dysfunction, chronotropic 
incompetence and β-blockade all have the potential to influence the VO2/work rate 
relationship 28-32. Indeed, approximately one fifth of the maximal CPET’s conducted 
demonstrated poor aerobic efficiency (ΔVO2/ΔWR slope <8.4 mL/min/W). ΔVO2/ΔWR 
slope was negatively correlated with estimated VO2peak measurement error (r=-0.496, 
p<0.001) indicating that estimates of VO2peak over-predict directly determined VO2peak 
when patients are aerobically ‘inefficient’. Inefficient cardiometabolic responses to 
exercise resulting in delayed oxygen kinetics, may prolong dependence on anaerobic 
metabolism 30 during sequential work rate transitions. In such instances, the 
assumptions of linearity between work rate and VO2 would not apply and work rate 
would therefore not be indicative of VO2. This issue is particularly pertinent above the 
VAT where VO2 steady-state attainment can take up to 15 minutes due to the 
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presence of a VO2 slow component. Steady state attainment above critical power i.e. 
near peak exercise, is not achieved 6. With this in mind, it is doubtful that any practical 
CPET protocol is truly capable of predicting VO2peak based on workload alone. 
Accurately predicting VO2peak or VO2peak changes in CHD patients, as evidenced by our 
findings and others 13 14 16, poses significant challenges, particularly at an individual 
patient level.  
 
Assessing functional capacity (by estimating METs) remains useful in the broad 
classification of baseline cardiorespiratory fitness and prognostic risk classification 
among participants attending for cardiac rehabilitation 33 However, poor agreement 
between estimated and directly determined changes in VO2peak questions the validity 
of this “widely used metric” in reporting CRF changes within CR settings. Our data 
require further validation in larger samples of cardiac rehabilitation patients. 
Practitioners should explore opportunities to integrate scientifically robust exercise 
testing techniques, such as CPET, in evaluating clinically meaningful improvements in 
CRF outcomes from exercise rehabilitation.  
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